Nicolas Laroudie

448 total citations
6 papers, 258 citations indexed

About

Nicolas Laroudie is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Nicolas Laroudie has authored 6 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 2 papers in Infectious Diseases. Recurrent topics in Nicolas Laroudie's work include Virus-based gene therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Nicolas Laroudie is often cited by papers focused on Virus-based gene therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Nicolas Laroudie collaborates with scholars based in France, Italy and Japan. Nicolas Laroudie's co-authors include Marina Radrizzani, Luigi Naldini, Anne Galy, Giuliana Vallanti, Otto-Wilhelm Merten, Sabine Charrier, Muriel Audit, Priyabrata Pattnaik, Fédor Svinartchouk and Florence Gonnet and has published in prestigious journals such as Biotechnology Advances, Vaccine and PROTEOMICS.

In The Last Decade

Nicolas Laroudie

6 papers receiving 249 citations

Peers

Nicolas Laroudie

MB

GENET

ID

ONCOL

EPIDE

Matthias Hebben France

Raymond D. Harris United States

Joanna Poutou Spain

Kerstin Schwarzwaelder Germany

Marlene Carmo United Kingdom

Anna Lengyel Hungary

Remko van der Vlugt Netherlands

Altar M. Munis United Kingdom

Heli Matilainen Finland

Christopher L. Chavez United States

Matthias Hebben France

Nicolas Laroudie

308 ×1.6

MB

296 ×1.7

GENET

83 ×1.2

ID

89 ×1.3

ONCOL

27 ×1.3

EPIDE

Citations per year, relative to Nicolas Laroudie Nicolas Laroudie (= 1×) peers Matthias Hebben

Countries citing papers authored by Nicolas Laroudie

Since Specialization

Citations

This map shows the geographic impact of Nicolas Laroudie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Laroudie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Laroudie more than expected).

Fields of papers citing papers by Nicolas Laroudie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Laroudie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Laroudie. The network helps show where Nicolas Laroudie may publish in the future.

Co-authorship network of co-authors of Nicolas Laroudie

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Laroudie. A scholar is included among the top collaborators of Nicolas Laroudie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Laroudie. Nicolas Laroudie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Laroudie, Nicolas & Quentin Bazot. (2024). Advancing gene therapy development with a multi-serotype AAV affinity resin. Cell and Gene Therapy Insights. 10(2). 237–253. 1 indexed citations

2.

Laroudie, Nicolas, et al.. (2022). Platform optimization for efficient AAV purification: insights from a CDMO. Cell and Gene Therapy Insights. 8(1). 145–158. 2 indexed citations

3.

Fedosyuk, Sofiya, Thomas M. Merritt, Marco Polo Peralta Álvarez, et al.. (2019). Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components. Vaccine. 37(47). 6951–6961. 24 indexed citations

4.

Laroudie, Nicolas, et al.. (2015). Clarification of vaccines: An overview of filter based technology trends and best practices. Biotechnology Advances. 34(1). 1–13. 59 indexed citations

5.

Merten, Otto-Wilhelm, Sabine Charrier, Nicolas Laroudie, et al.. (2010). Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application. Human Gene Therapy. 22(3). 343–356. 146 indexed citations

6.

Laroudie, Nicolas, Florence Gonnet, Luigi Naldini, et al.. (2009). Quantitative proteomic analysis of lentiviral vectors using 2‐DE. PROTEOMICS. 9(14). 3666–3676. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact